Impact of Salinomycin on human cholangiocarcinoma: induction of apoptosis and impairment of tumor cell proliferation in vitro

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Lieke, Thorsten ^a   Ramackers, Wolf ^a   Bergmann, Sabine ^a   Klempnauer, Jürgen ^a   Winkler, Michael ^a   Klose, Johannes ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Apoptosis; Cell cycle; Cholangiocarcinoma; Salinomycin; Tumor cell migration

Indexed keywords

LIPOCORTIN 5; SALINOMYCIN;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CANCER RESISTANCE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL MIGRATION; CONTROLLED STUDY; DRUG RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; NICK END LABELING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CASPASES; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHOLANGIOCARCINOMA; ENZYME ACTIVATION; HUMANS; PYRANS;

EID: 84867236809     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-466     Document Type: Article

References (44)

1. Lazaridis KN, Gores GJ. Cholangiocarcinoma. Gastroenterology 2005, 128(6):1655-1667. 10.1053/j.gastro.2005.03.040, 15887157.
2. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004, 24(2):115-125. 10.1055/s-2004-828889, 15192785.
3. Welzel TM, McGlynn KA, Hsing AW, O'Brien TR, Pfeiffer RM. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 2006, 98(12):873-875. 10.1093/jnci/djj234, 16788161.
4. Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 2008, 48(1):308-321. 10.1002/hep.22310, 2547491, 18536057.
5. Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BJ, Youssef BM, Klimstra D, Blumgart LH. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001, 234(4):507-517. discussion 517-509, 10.1097/00000658-200110000-00010, 1422074, 11573044.
6. Rea DJ, Rosen CB, Nagorney DM, Heimbach JK, Gores GJ. Transplantation for cholangiocarcinoma: when and for whom?. Surg Oncol Clin N Am 2009, 18(2):325-337. ix, 10.1016/j.soc.2008.12.008, 19306815.
7. Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 2010, 362(14):1273-1281. 10.1056/NEJMoa0908721, 20375404.
8. Wise C, Pilanthananond M, Perry BF, Alpini G, McNeal M, Glaser SS. Mechanisms of biliary carcinogenesis and growth. World J Gastroenterol 2008, 14(19):2986-2989. 10.3748/wjg.14.2986, 2712163, 18494047.
9. Miyazaki Y, Shibuya M, Sugawara H, Kawaguchi O, Hirsoe C. Salinomycin, a new polyether antibiotic. J Antibiot (Tokyo) 1974, 27(11):814-821.
10. Mitani M, Yamanishi T, Miyazaki Y. Salinomycin: a new monovalent cation ionophore. Biochem Biophys Res Commun 1975, 66(4):1231-1236. 10.1016/0006-291X(75)90490-8, 1191289.
11. Mitani M, Yamanishi T, Miyazaki Y, Otake N. Salinomycin effects on mitochondrial ion translocation and respiration. Antimicrob Agents Chemother 1976, 9(4):655-660. 10.1128/AAC.9.4.655, 429593, 131509.
12. Daugschies A, Gasslein U, Rommel M. Comparative efficacy of anticoccidials under the conditions of commercial broiler production and in battery trials. Vet Parasitol 1998, 76(3):163-171. 10.1016/S0304-4017(97)00203-3, 9615950.
13. Callaway TR, Edrington TS, Rychlik JL, Genovese KJ, Poole TL, Jung YS, Bischoff KM, Anderson RC, Nisbet DJ. Ionophores: their use as ruminant growth promotants and impact on food safety. Curr Issues Intest Microbiol 2003, 4(2):43-51.
14. Lindemann MD, Kornegay ET, Stahly TS, Cromwell GL, Easter RA, Kerr BJ, Lucas DM. The efficacy of salinomycin as a growth promotant for swine from 9 to 97 kg. J Anim Sci 1985, 61(4):782-788.
15. Naujokat C, Fuchs D, Opelz G. Salinomycin in cancer: A new mission for an old agent. Mol Med Report 2010, 3(4):555-559.
16. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, Lander ES. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009, 138(4):645-659. 10.1016/j.cell.2009.06.034, 19682730.
17. Kim JH, Chae M, Kim WK, Kim YJ, Kang HS, Kim HS, Yoon S. Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein. Br J Pharmacol 2011, 162(3):773-784. 10.1111/j.1476-5381.2010.01089.x, 3041264, 20973777.
18. Dong TT, Zhou HM, Wang LL, Feng B, Lv B, Zheng MH. Salinomycin selectively targets 'CD133+' cell subpopulations and decreases malignant traits in colorectal cancer lines. Ann Surg Oncol 2011, 18(6):1797-1804. 10.1245/s10434-011-1561-2, 21267784.
19. Fuchs D, Daniel V, Sadeghi M, Opelz G, Naujokat C. Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. Biochem Biophys Res Commun 2010, 394(4):1098-1104. 10.1016/j.bbrc.2010.03.138, 20350531.
20. Fuchs D, Heinold A, Opelz G, Daniel V, Naujokat C. Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells. Biochem Biophys Res Commun 2009, 390(3):743-749. 10.1016/j.bbrc.2009.10.042, 19835841.
21. Saijyo S, Kudo T, Suzuki M, Katayose Y, Shinoda M, Muto T, Fukuhara K, Suzuki T, Matsuno S. Establishment of a new extrahepatic bile duct carcinoma cell line, TFK-1. Tohoku J Exp Med 1995, 177(1):61-71. 10.1620/tjem.177.61, 8693487.
22. Knuth A, Gabbert H, Dippold W, Klein O, Sachsse W, Bitter-Suermann D, Prellwitz W, Buschenfelde KH M. Biliary adenocarcinoma. Characterisation of three new human tumor cell lines. J Hepatol 1985, 1(6):579-596. 10.1016/S0168-8278(85)80002-7, 4056357.
23. International Conference on Tumor Necrosis Factor and Related Cytotoxins September 14-18, 1987, Heidelberg, Federal Republic of Germany. Abstracts. Immunobiology 1987, 175(1-2):1-143. International Conference on Tumor Necrosis Factor and Related Cytotoxins.
24. Ishimura N, Isomoto H, Bronk SF, Gores GJ. Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells. Am J Physiol Gastrointest Liver Physiol 2006, 290(1):G129-136.
25. Fingas CD, Blechacz BR, Smoot RL, Guicciardi ME, Mott J, Bronk SF, Werneburg NW, Sirica AE, Gores GJ. A smac mimetic reduces TNF related apoptosis inducing ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cells. Hepatology 2010, 52(2):550-561. 10.1002/hep.23729, 2957364, 20683954.
26. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005, 366(9493):1303-1314. 10.1016/S0140-6736(05)67530-7, 16214602.
27. Baradari V, Hopfner M, Huether A, Schuppan D, Scherubl H. Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells. World J Gastroenterol 2007, 13(33):4458-4466.
28. Fingas CD, Mertens JC, Razumilava N, Bronk SF, Sirica AE, Gores GJ. Targeting PDGFR-beta in Cholangiocarcinoma. Liver Int 2012, 32(3):400-409.
29. Takayama Y, Kokuryo T, Yokoyama Y, Ito S, Nagino M, Hamaguchi M, Senga T. Silencing of Tousled-like kinase 1 sensitizes cholangiocarcinoma cells to cisplatin-induced apoptosis. Cancer Lett 2010, 296(1):27-34. 10.1016/j.canlet.2010.03.011, 20381954.
30. Yun BR, Lee MJ, Kim JH, Kim IH, Yu GR, Kim DG. Enhancement of parthenolide-induced apoptosis by a PKC-alpha inhibition through heme oxygenase-1 blockage in cholangiocarcinoma cells. Exp Mol Med 2010, 42(11):787-797. 10.3858/emm.2010.42.11.082, 2992858, 20938215.
31. Lu D, Choi MY, Yu J, Castro JE, Kipps TJ, Carson DA. Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells. Proc Natl Acad Sci U S A 2011, 108(32):13253-13257. 10.1073/pnas.1110431108, 3156152, 21788521.
32. Ketola K, Hilvo M, Hyotylainen T, Vuoristo A, Ruskeepaa AL, Oresic M, Kallioniemi O, Iljin K. Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress. Br J Cancer 2012, 106(1):99-106. 10.1038/bjc.2011.530, 22215106.
33. Salvesen GS. Caspases and apoptosis. Essays Biochem 2002, 38:9-19.
34. Salvesen GS. Caspases: opening the boxes and interpreting the arrows. Cell Death Differ 2002, 9(1):3-5. 10.1038/sj.cdd.4400963, 11803369.
35. Wang Z, Tang X, Zhang Y, Qi R, Li Z, Zhang K, Liu Z, Yang X. Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE. Biomed Pharmacother 2012, 66(3):161-166. 10.1016/j.biopha.2011.09.008, 22425181.
36. Liu CC, Prior J, Piwnica-Worms D, Bu G. LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy. Proc Natl Acad Sci U S A 2010, 107(11):5136-5141. 10.1073/pnas.0911220107, 2841938, 20194742.
37. Tokumoto N, Ikeda S, Ishizaki Y, Kurihara T, Ozaki S, Iseki M, Shimizu Y, Itamoto T, Arihiro K, Okajima M, et al. Immunohistochemical and mutational analyses of Wnt signaling components and target genes in intrahepatic cholangiocarcinomas. Int J Oncol 2005, 27(4):973-980.
38. Wachter J, Neureiter D, Alinger B, Pichler M, Fuereder J, Oberdanner C, Di Fazio P, Ocker M, Berr F, Kiesslich T. Influence of five potential anticancer drugs on wnt pathway and cell survival in human biliary tract cancer cells. Int J Biol Sci 2012, 8(1):15-29. 3226029, 22211101.
39. Kim KY, Yu SN, Lee SY, Chun SS, Choi YL, Park YM, Song CS, Chatterjee B, Ahn SC. Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization. Biochem Biophys Res Commun 2011, 413(1):80-86. 10.1016/j.bbrc.2011.08.054, 21871443.
40. Kim JH, Yoo HI, Kang HS, Ro J, Yoon S. Salinomycin sensitizes antimitotic drugs-treated cancer cells by increasing apoptosis via the prevention of G2 arrest. Biochem Biophys Res Commun 2012, 418(1):98-103. 10.1016/j.bbrc.2011.12.141, 22244892.
41. Kim WK, Kim JH, Yoon K, Kim S, Ro J, Kang HS, Yoon S. Salinomycin, a p-glycoprotein inhibitor, sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrest. Invest New Drugs 2012, 30(4):1311-1318. 10.1007/s10637-011-9685-6, 21573958.
42. Story P, Doube A. A case of human poisoning by salinomycin, an agricultural antibiotic. N Z Med J 2004, 117(1190):U799.
43. Plumlee KH, Johnson B, Galey FD. Acute salinomycin toxicosis of pigs. J Vet Diagn Invest 1995, 7(3):419-420. 10.1177/104063879500700327, 7578468.
44. Kosal ME, Anderson DE. An unaddressed issue of agricultural terrorism: a case study on feed security. J Anim Sci 2004, 82(11):3394-3400.